Virtual Medicinal Product (VMP) - Gliclazide 30mg modified-release tablets

Navigation

Name Details

Name Start Date End Date
Name Current Name Gliclazide 30mg modified-release tablets Start Date 16-01-2003 End Date

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
tablet
Unit Dose UOM
tablet

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Oral
Form
Modified-release tablet
Ontology Form/Route
tabletmodified-release.oral
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
A10BB09
BNF Start Date End Date
Current BNF 06010201 Start Date 04-04-2022 End Date
Previous BNF 06010201 Start Date 02-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
38896211000001104 19-08-2020
134587001 16-01-2003 18-08-2020

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Gliclazide Based on Ingredient Substance 30 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
28 tablet 281 Part VIIIA Category C
30 tablet
56 tablet
60 tablet
84 tablet
112 tablet